Incidence rate of MAT events, stratified by age: incidence rate ratio of observed MAT events in PBSC donors and BM donors by age
| Age, years . | 18-29 . | 30-39 . | 40-49 . | 50+ . |
|---|---|---|---|---|
| Myeloid | ||||
| Rate ratio | NE | NE | 0.70 | NE |
| 95% CI | 0.04-11.2 | |||
| P value | .80 | |||
| Lymphoid | ||||
| Rate ratio | 2.09 | 1.20 | 1.75 | 0.34 |
| 95% CI | 0.23-18.7 | 0.29-5.00 | 0.34-9.01 | 0.08-1.53 |
| P value | .51 | .81 | .50 | .16 |
| Other malignancies | ||||
| Rate ratio | 0.61 | 0.81 | 0.98 | 0.89 |
| 95% CI | 0.40-0.92 | 0.61-1.07 | 0.80-1.21 | 0.68-1.17 |
| P value | .02∗ | .1344 | .87 | .41 |
| Autoimmune | ||||
| Rate ratio | 0.98 | 1.42 | 0.93 | 0.74 |
| 95% CI | 0.73-1.30 | 1.06-1.89 | 0.70-1.24 | 0.48-1.13 |
| P value | .86 | .02∗ | .62 | .16 |
| Thrombosis | ||||
| Rate ratio | 0.69 | 1.04 | 1.24 | 1.01 |
| 95% CI | 0.38-1.24 | 0.63-1.69 | 0.81-1.88 | 0.54-1.90 |
| P value | .21 | .89 | .32 | .97 |
| Age, years . | 18-29 . | 30-39 . | 40-49 . | 50+ . |
|---|---|---|---|---|
| Myeloid | ||||
| Rate ratio | NE | NE | 0.70 | NE |
| 95% CI | 0.04-11.2 | |||
| P value | .80 | |||
| Lymphoid | ||||
| Rate ratio | 2.09 | 1.20 | 1.75 | 0.34 |
| 95% CI | 0.23-18.7 | 0.29-5.00 | 0.34-9.01 | 0.08-1.53 |
| P value | .51 | .81 | .50 | .16 |
| Other malignancies | ||||
| Rate ratio | 0.61 | 0.81 | 0.98 | 0.89 |
| 95% CI | 0.40-0.92 | 0.61-1.07 | 0.80-1.21 | 0.68-1.17 |
| P value | .02∗ | .1344 | .87 | .41 |
| Autoimmune | ||||
| Rate ratio | 0.98 | 1.42 | 0.93 | 0.74 |
| 95% CI | 0.73-1.30 | 1.06-1.89 | 0.70-1.24 | 0.48-1.13 |
| P value | .86 | .02∗ | .62 | .16 |
| Thrombosis | ||||
| Rate ratio | 0.69 | 1.04 | 1.24 | 1.01 |
| 95% CI | 0.38-1.24 | 0.63-1.69 | 0.81-1.88 | 0.54-1.90 |
| P value | .21 | .89 | .32 | .97 |
NE, not evaluable; CI, Confidence Interval.
Statistically significant result (P < .05).